Xvivo Perfusion’s stock price target has recently been reaffirmed at SEK 319.6 following the latest analyst review, with a slight increase in the discount rate to 5.77 percent. Revenue growth ...
Ten years after transplantation, donor kidneys that were pumped on a machine still do better than those that underwent static storage ...
WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today the completion of the world’s first donor kidney ...
Tulyp Medical Inc. has emerged from stealth mode with a pressure-driven perfusion system designed to improve vascular procedures. The company, born out of Sofinnova Partners' medical device ...
Medical Device Network on MSN
Sofinnova spinoff Tulyp Medical emerges from stealth with perfusion tech
Tulyp Medical has emerged from stealth with its pressure-driven perfusion system for vascular procedures and submitted a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback